- NEWS AND VIEWS
Blood’s life history traced through genomic scars
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 606, 255-256 (2022)
doi: https://doi.org/10.1038/d41586-022-01304-y
References
Mitchell, E. et al. Nature 606, 343–350 (2022).
Fabre, M. A. et al. Nature 606, 335–342 (2022).
Jaiswal, S. et al. N. Engl. J. Med. 371, 2488–2498 (2014).
Vuckovic, D. et al. Cell 182, 1214–1231 (2020).
Chen, M.-H. et al. Cell 182, 1198–1213 (2020).
Bick, A. G. et al. Nature 586, 763–768 (2020).
Nam, A. S. et al. Nature 571, 355–360 (2019).
Bao, E. L. et al. Nature 586, 769–775 (2020).
Weinstock, J. S. et al. Preprint at bioRxiv https://doi.org/10.1101/2021.12.10.471810 (2021).
Competing Interests
B.L.E. has received research funding from Celgene, Deerfield, Novartis and Calico, and consulting fees from GRAIL. He is a member of the scientific advisory board and shareholder for Neomorph Therapeutics, TenSixteen Bio, Skyhawk Therapeutics and Exo Therapeutics.